These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

903 related articles for article (PubMed ID: 35107989)

  • 1. Chemical and Biomolecular Strategies for STING Pathway Activation in Cancer Immunotherapy.
    Garland KM; Sheehy TL; Wilson JT
    Chem Rev; 2022 Mar; 122(6):5977-6039. PubMed ID: 35107989
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mini-review: the distinct roles of STING signaling in tumor immunity-recent progress.
    Wang S; Li T; Sun H; Chen D; Xu H; Hao J
    J Leukoc Biol; 2023 Jul; 114(2):111-115. PubMed ID: 37141382
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacological Activation of cGAS for Cancer Immunotherapy.
    Garland KM; Rosch JC; Carson CS; Wang-Bishop L; Hanna A; Sevimli S; Van Kaer C; Balko JM; Ascano M; Wilson JT
    Front Immunol; 2021; 12():753472. PubMed ID: 34899704
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Manganese is critical for antitumor immune responses via cGAS-STING and improves the efficacy of clinical immunotherapy.
    Lv M; Chen M; Zhang R; Zhang W; Wang C; Zhang Y; Wei X; Guan Y; Liu J; Feng K; Jing M; Wang X; Liu YC; Mei Q; Han W; Jiang Z
    Cell Res; 2020 Nov; 30(11):966-979. PubMed ID: 32839553
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Unlocking the promise of systemic STING agonist for cancer immunotherapy.
    Sun X; Zhou X; Lei YL; Moon JJ
    J Control Release; 2023 May; 357():417-421. PubMed ID: 37001564
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Potent STING activation stimulates immunogenic cell death to enhance antitumor immunity in neuroblastoma.
    Wang-Bishop L; Wehbe M; Shae D; James J; Hacker BC; Garland K; Chistov PP; Rafat M; Balko JM; Wilson JT
    J Immunother Cancer; 2020 Mar; 8(1):. PubMed ID: 32169869
    [TBL] [Abstract][Full Text] [Related]  

  • 7. STING Signaling in Cancer Cells: Important or Not?
    Sokolowska O; Nowis D
    Arch Immunol Ther Exp (Warsz); 2018 Apr; 66(2):125-132. PubMed ID: 28748479
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chemical Biology Perspectives on STING Agonists as Tumor Immunotherapy.
    Xuan C; Hu R
    ChemMedChem; 2023 Dec; 18(23):e202300405. PubMed ID: 37794702
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nanoparticle-Mediated STING Agonist Delivery for Enhanced Cancer Immunotherapy.
    Zhou Q; Zhou Y; Li T; Ge Z
    Macromol Biosci; 2021 Aug; 21(8):e2100133. PubMed ID: 34117839
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development of small molecule inhibitors/agonists targeting STING for disease.
    Liu K; Lan Y; Li X; Li M; Cui L; Luo H; Luo L
    Biomed Pharmacother; 2020 Dec; 132():110945. PubMed ID: 33254439
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Activation of Stimulation of Interferon Genes (STING) Signal and Cancer Immunotherapy.
    Luo K; Li N; Ye W; Gao H; Luo X; Cheng B
    Molecules; 2022 Jul; 27(14):. PubMed ID: 35889509
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Development of STING Agonists and Emerging Results as a Cancer Immunotherapy.
    Hines JB; Kacew AJ; Sweis RF
    Curr Oncol Rep; 2023 Mar; 25(3):189-199. PubMed ID: 36705879
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Targeting STING for cancer immunotherapy: From mechanisms to translation.
    Huang R; Ning Q; Zhao J; Zhao X; Zeng L; Yi Y; Tang S
    Int Immunopharmacol; 2022 Dec; 113(Pt A):109304. PubMed ID: 36252492
    [TBL] [Abstract][Full Text] [Related]  

  • 14. cGAS-STING signaling in cancer immunity and immunotherapy.
    Du H; Xu T; Cui M
    Biomed Pharmacother; 2021 Jan; 133():110972. PubMed ID: 33254021
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Insight into the dichotomous regulation of STING activation in immunotherapy.
    Hu Z; Yang Y; Fang L; Zhou J; Zhang H
    Immunopharmacol Immunotoxicol; 2021 Apr; 43(2):126-137. PubMed ID: 33618600
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacological Modulation of the STING Pathway for Cancer Immunotherapy.
    Berger G; Marloye M; Lawler SE
    Trends Mol Med; 2019 May; 25(5):412-427. PubMed ID: 30885429
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mannosylated STING Agonist Drugamers for Dendritic Cell-Mediated Cancer Immunotherapy.
    Nguyen DC; Song K; Jokonya S; Yazdani O; Sellers DL; Wang Y; Zakaria A; Pun SH; Stayton PS
    ACS Cent Sci; 2024 Mar; 10(3):666-675. PubMed ID: 38559305
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nanomaterial-encapsulated STING agonists for immune modulation in cancer therapy.
    Chen X; Xu Z; Li T; Thakur A; Wen Y; Zhang K; Liu Y; Liang Q; Liu W; Qin JJ; Yan Y
    Biomark Res; 2024 Jan; 12(1):2. PubMed ID: 38185685
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The cGAS/STING Pathway: A Novel Target for Cancer Therapy.
    Gan Y; Li X; Han S; Liang Q; Ma X; Rong P; Wang W; Li W
    Front Immunol; 2021; 12():795401. PubMed ID: 35046953
    [TBL] [Abstract][Full Text] [Related]  

  • 20. STING activation normalizes the intraperitoneal vascular-immune microenvironment and suppresses peritoneal carcinomatosis of colon cancer.
    Lee SJ; Yang H; Kim WR; Lee YS; Lee WS; Kong SJ; Lee HJ; Kim JH; Cheon J; Kang B; Chon HJ; Kim C
    J Immunother Cancer; 2021 Jun; 9(6):. PubMed ID: 34145029
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 46.